Literature DB >> 21334826

An outbreak of a multiresistant methicillin-susceptible Staphylococcus aureus (MR-MSSA) strain in a burn centre: the importance of routine molecular typing.

S A Boers1, I van Ess, S M Euser, R Jansen, F R H Tempelman, B M W Diederen.   

Abstract

Here we report an outbreak among 17 patients caused by a single strain of a multiresistant methicillin-susceptible Staphylococcus aureus (MR-MSSA) in a burn centre. The MR-MSSA strains were resistant to penicillin, ciprofloxacin, erythromycin, clindamycin and co-trimoxazole. Further analysis showed an increased prevalence of MR-MSSA carriership in S. aureus colonized patients admitted to the burn centre, from 0% in 2005 (0/118), 3.3% in 2006 (4/121), 6.1% in 2007 (6/99), to 7.8% in 2008 (7/90). Molecular typing with amplified fragment length polymorphism showed that all MR-MSSA isolates derived from burn centre patients had a unique genotype, and was different compared to isolates derived from other hospital patients. All healthcare workers (HCWs) who worked in the burn centre during the outbreak were screened for nasal carriage with MR-MSSA. One HCW tested positive for a genotype of MR-MSSA that was indistinguishable from the genotype found in samples of the burned patients. No new cases of MR-MSSA colonization or infection were identified after the colonized HCW stopped working at the burn centre. The routine practice of molecular typing of collected S. aureus strains from both patients and HCWs will help to detect nosocomial spread in a burn centre, and opens the possibility of a rapid, almost pre-emptive response.
Copyright © 2011 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21334826     DOI: 10.1016/j.burns.2011.01.005

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  7 in total

1.  Long-term persistence of a multi-resistant methicillin-susceptible Staphylococcus aureus (MR-MSSA) clone at a university hospital in southeast Sweden, without further transmission within the region.

Authors:  M Lindqvist; B Isaksson; J Swanberg; R Skov; A R Larsen; J Larsen; A Petersen; A Hällgren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-03-27       Impact factor: 3.267

2.  Outbreak column 14: Staphylococcus aureus - new outbreaks of old infections.

Authors:  Evonne T Curran
Journal:  J Infect Prev       Date:  2014-06-30

3.  The effect of clary sage oil on staphylococci responsible for wound infections.

Authors:  Monika Sienkiewicz; Anna Głowacka; Katarzyna Poznańska-Kurowska; Andrzej Kaszuba; Anna Urbaniak; Edward Kowalczyk
Journal:  Postepy Dermatol Alergol       Date:  2015-02-03       Impact factor: 1.837

4.  The prevalence of exotoxins, adhesion, and biofilm-related genes in Staphylococcus aureus isolates from the main burn center of Tehran, Iran.

Authors:  Zahra Mir; Narges Nodeh Farahani; Sara Abbasian; Faranak Alinejad; Mahboubeh Sattarzadeh; Ramin Pouriran; Mostafa Dahmardehei; Mehdi Mirzaii; Seyed Sajjad Khoramrooz; Davood Darban-Sarokhalil
Journal:  Iran J Basic Med Sci       Date:  2019-11       Impact factor: 2.699

5.  Aromatic Compound-Dependent Staphylococcus aureus Is Safe in a Nasal Colonization Leukopenic Murine Model.

Authors:  María S Barbagelata; Lucía P Alvarez; Cristian M Dotto; Santiago M Lattar; Daniel O Sordelli; Fernanda R Buzzola
Journal:  Int J Microbiol       Date:  2012-08-05

6.  Staphylococcus aureus in a neonatal care center: methicillin-susceptible strains should be a main concern.

Authors:  Sara Romano-Bertrand; Anne Filleron; Renaud Mesnage; Anne Lotthé; Marie Noëlle Didelot; Lydie Burgel; Estelle Jumas Bilak; Gilles Cambonie; Sylvie Parer
Journal:  Antimicrob Resist Infect Control       Date:  2014-07-01       Impact factor: 4.887

7.  Antimicrobial activity of geranium oil against clinical strains of Staphylococcus aureus.

Authors:  Monika Bigos; Małgorzata Wasiela; Danuta Kalemba; Monika Sienkiewicz
Journal:  Molecules       Date:  2012-08-28       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.